Following a highly successful launch in 2011, the UK-India MedChem Congress returns this year to showcase some of the latest research, technologies and solutions developed by medicinal chemists across the world.
Co-organised by the 91AV (RSC), Indian Institute of Chemical Technology Hyderabad (IICT) and Open Source Drug Discovery (OSDD), this popular event will bring together academics and industrialists to facilitate research collaborations in the area of medicinal chemistry.
Speakers
Dr Anthony Addlagatta, IICT, India
Dr Sudershan Arora, Ranbaxy Research, India
Dr Clifton E Barry III, National Institute of Allergy and Infectious Diseases, USA
Dr Paul Brennan, SGC, University of Oxford, UK
Dr Ian A Cliffe, Daiichi Sankyo India Pvt. Ltd, Gurgaon, India
Professor Ian Gilbert, University of Dundee, UK
Professor Javed Iqbal, Institute of Life Sciences, Hyderabad, India
Dr Sarma ARP Jagarlapudi, GVK Biosciences, Hyderabad, India
Professor Krishna Kaliappan, Indian Institute of Technology, Mumbai, India
Dr S B Katti, CSIR - Central Drug Research Institute, Lucknow, India
Dr Sanjay Kumar, Piramal Life Science Ltd., Mumbai, India
Professor Goverdhan Mehta, University of Hyderabad, India
Professor Subhash Pandhye, University of Pune, India
Professor Barry Potter, University of Bath, UK
Dr G N Sastry, IICT, India
Professor Anamik Shah, Saurashtra University, Gujarat, India
Dr Paul Smith, Novartis, Singapore
Dr Hans-Ulrich Stilz, Sanofi Aventis, Germany
Dr Hosahalli Subramanya, Aurigene Discovery Technologies, Bangalore, India
Scientific Committee
Dr Dave Alker, RSC Organic Division, UK
Dr Saibal Das, IICT, India
Professor Ray Jones, RSC Organic Division and Loughborough University, UK
Dr Ahmed Kamal, IICT and NIPER, India
Dr Richard Kelly, RSC, UK
Dr Alejandra Palermo, RSC, UK
Dr Chandra Ramarao, AVRA Laboratories, India
Dr Haridas Rode, CSIR-OSDD, India
Co-organised by the 91AV (RSC), Indian Institute of Chemical Technology Hyderabad (IICT) and Open Source Drug Discovery (OSDD), this popular event will bring together academics and industrialists to facilitate research collaborations in the area of medicinal chemistry.
Speakers
Dr Anthony Addlagatta, IICT, India
Dr Sudershan Arora, Ranbaxy Research, India
Dr Clifton E Barry III, National Institute of Allergy and Infectious Diseases, USA
Dr Paul Brennan, SGC, University of Oxford, UK
Dr Ian A Cliffe, Daiichi Sankyo India Pvt. Ltd, Gurgaon, India
Professor Ian Gilbert, University of Dundee, UK
Professor Javed Iqbal, Institute of Life Sciences, Hyderabad, India
Dr Sarma ARP Jagarlapudi, GVK Biosciences, Hyderabad, India
Professor Krishna Kaliappan, Indian Institute of Technology, Mumbai, India
Dr S B Katti, CSIR - Central Drug Research Institute, Lucknow, India
Dr Sanjay Kumar, Piramal Life Science Ltd., Mumbai, India
Professor Goverdhan Mehta, University of Hyderabad, India
Professor Subhash Pandhye, University of Pune, India
Professor Barry Potter, University of Bath, UK
Dr G N Sastry, IICT, India
Professor Anamik Shah, Saurashtra University, Gujarat, India
Dr Paul Smith, Novartis, Singapore
Dr Hans-Ulrich Stilz, Sanofi Aventis, Germany
Dr Hosahalli Subramanya, Aurigene Discovery Technologies, Bangalore, India
Scientific Committee
Dr Dave Alker, RSC Organic Division, UK
Dr Saibal Das, IICT, India
Professor Ray Jones, RSC Organic Division and Loughborough University, UK
Dr Ahmed Kamal, IICT and NIPER, India
Dr Richard Kelly, RSC, UK
Dr Alejandra Palermo, RSC, UK
Dr Chandra Ramarao, AVRA Laboratories, India
Dr Haridas Rode, CSIR-OSDD, India
